WGRX
DataMeds AI, Inc.
Key Financials
Revenue
$23.3M
↑ 28.7%
Net Income
$-101274530
↓ 1377.1%
Gross Profit
$-6426419
↓ 463.6%
Operating Income
$-93749097
↓ 1425.6%
Total Assets
$30.5M
↓ 46.9%
EPS (Diluted)
$-1.43
↓ 853.3%
Total Liabilities
$42.9M
↓ 15.2%
Shareholders' Equity
$-12447801.00
↓ 284.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/18/2026 | View on SEC |
| 10-Q | 8/17/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
| NT 10-Q | 8/14/2026 | View on SEC |
| S-1 | 8/7/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 8-K | 7/21/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
| 4 | 6/25/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | WGRX |
| Company Name | DataMeds AI, Inc. |
| CIK | 2030763 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 1-843-302-1785 |